"How long does a lyophilized peptide last?" is one of the most searched questions in this field, and most answers online give a single confident number. The honest answer is that there is no single number. Shelf life is a property of a specific material, in a specific container, stored under specific conditions, and it has to be established by testing.
This guide explains what the published stability literature actually says about freeze-dried (lyophilized) peptides and proteins, which factors control how long a sealed vial stays within specification, and how to read the dates and storage conditions a supplier prints on a label. It covers sealed, dry material only.
Why "shelf life" has no universal answer
Shelf life means the period during which a material stays within its specification (for example, purity above a stated minimum) when stored under its labeled conditions. It is set by measuring the material at intervals during storage and seeing when, if ever, it drifts out of spec.
That makes it specific to:
- the sequence (some amino acids are more reactive than others);
- the salt form and any excipients in the powder;
- the residual moisture left after freeze-drying;
- the container and seal;
- the storage temperature, light exposure and handling.
Change any one of these and the shelf life can change. A number quoted for one peptide from one maker doesn't transfer to another.
Why peptides are freeze-dried at all
Peptides and proteins are generally more stable dry than in solution, because many degradation reactions need water or run faster in it. A widely cited review of solid protein pharmaceuticals explains that proteins "often have to be made into solid forms to achieve an acceptable shelf life," and that lyophilization is the most common way to do it (Wang, International Journal of Pharmaceutics, 2000; DOI: 10.1016/s0378-5173(00)00423-3).
The same review adds the important caveat: even after successful lyophilization, material in the solid state "may still have limited long-term storage stability." Dry slows degradation. It does not stop it.
What the stability data shows
Dry is much slower than wet, but not zero
A University of Kansas study measured asparagine deamidation (a common chemical degradation route) in two model peptides, in solution and in lyophilized solids, at 50 °C. The peptides degraded 2- to 80-fold more slowly in the solid formulations than in solution, and the size of the difference depended on the solid matrix: sucrose protected against deamidation more than mannitol in the solid state (Li et al., Journal of Pharmaceutical Sciences, 2005; DOI: 10.1002/jps.20372).
Two practical lessons follow. First, freeze-drying buys a great deal of stability. Second, what else is in the powder matters, which is one reason two suppliers' versions of the "same" peptide can age differently.
The history of the solution before drying matters
An earlier Kansas study of a lyophilized model hexapeptide containing asparagine found that the pH of the solution the peptide was dried from had a significant effect on deamidation in the solid state, with better stability in a slightly acidic range (pH 3–5). In that study, moisture and temperature effects were less significant than pH, and pH determined how much the peptide's stability depended on them (Oliyai et al., Journal of Pharmaceutical Science and Technology, 1994).
For a buyer, this is a reminder that shelf life is partly baked in at manufacture. You can protect what's there. You can't add stability back.
Moisture: less is usually better, but not always
Residual moisture is one of the main levers on solid-state stability. A Genentech study stored a lyophilized antibody formulation with residual moisture from 1% to 8% at temperatures from 5 to 50 °C for 6 or 12 months. All formulations were stable at 5 °C. At higher temperatures, higher moisture reduced chemical stability, while intermediate moisture was actually more stable to aggregation than the driest samples (Breen et al., Pharmaceutical Research, 2001; DOI: 10.1023/a:1013054431517). An earlier Genentech paper reached a similar conclusion for other proteins: "the drier the better" may not always hold, and an optimum residual moisture may exist (Hsu et al., Developments in Biological Standardization, 1992).
These studies used large proteins, not short peptides, so the specific numbers don't carry over. The pattern does: cold storage protects, and uncontrolled moisture uptake is a risk.
More recent work from TU Dortmund and LMU Munich proposes combining water activity with glass-transition temperature to predict long-term stability of lyophilized formulations, and reports high long-term stability within a water activity range of 0.025–0.25 in their validation studies (Zäh et al., Molecular Pharmaceutics, 2025; DOI: 10.1021/acs.molpharmaceut.4c01106). The direction of the field is toward measuring the state of the water in the cake, not just the amount.
Temperature: the one you control most
Across this literature, degradation speeds up with temperature. In the Breen study, chemical and physical degradation in the glassy state followed Arrhenius kinetics, the standard relationship in which reaction rates rise with temperature. That is the reasoning behind refrigerated or frozen storage for sealed dry material, and behind accelerated stability testing, where samples are held warm to reveal slow degradation sooner.
A broad review of protein pharmaceutical stability covers both chemical instability (such as oxidation and deamidation) and physical instability (such as aggregation), how they interact, and how stabilization differs between the dissolved and dried states (Manning et al., Pharmaceutical Research, 2010; DOI: 10.1007/s11095-009-0045-6).
Which sequences age faster
Some amino acids are known weak points:
- Asparagine (N) and glutamine (Q) can deamidate, especially when asparagine is followed by glycine.
- Methionine (M), cysteine (C) and tryptophan (W) are prone to oxidation, driven by oxygen and light.
- Aspartic acid (D) can isomerize.
A peptide rich in these residues is likely to be more sensitive to storage conditions than one without them. That's a reason to follow the labeled storage condition closely rather than a generic rule of thumb.
Reading dates on a label or COA
Suppliers use a few different terms:
- Expiry or "use by" date. The date after which the supplier no longer stands behind the specification, under the labeled storage condition.
- Retest date. The date by which the material should be re-analyzed to confirm it's still in spec. Common for research materials that don't have full shelf-life studies.
- Manufacture or test date. When the lot was made or analyzed. Useful for knowing a lot's age.
What to check:
- The date is tied to a lot number that matches your vial.
- The storage condition the date assumes is stated (for example 2–8 °C, or −20 °C).
- You know whether the date comes from actual stability testing or is a general policy.
If a vial has been stored outside its labeled condition, the printed date no longer applies with confidence. Record the excursion and decide whether the lot is still fit for your work. Our guide to peptide storage temperatures covers this. Related reading: Peptide Storage Temperatures: Freezer, Fridge, and Room-Temperature Handling for Lab Stock.
Signs a sealed vial may have aged badly
Only analysis can confirm a change, but a visual check on each sealed vial is a sensible first screen:
- a cake that has collapsed, shrunk or looks melted;
- discoloration compared with the COA's appearance description;
- visible moisture or a sticky texture;
- a broken or loose seal.
Any of these is a reason to set the vial aside and check before use.
Practical rules for sealed stock
- Follow the labeled storage condition. It overrides any general guidance, including this article.
- Keep vials sealed, dry and dark until needed.
- Let a cold vial reach room temperature before opening, so moisture doesn't condense on the cake.
- Rotate stock first in, first out, by lot.
- Log receipt date, lot and any excursion.
How Seratide handles dates and lots
Every Seratide vial carries a lot number linked to a record on the Lot lookup page. The records there today are clearly labeled layout samples showing the format, with placeholder values; issued laboratory reports replace them as lots are analyzed. Shipping and packing details are on our Shipping Policy page.
Sources
All sources below were opened and their PubMed abstracts read on 2026-09-29. Claims are limited to what the abstracts state.
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PubMed: https://pubmed.ncbi.nlm.nih.gov/10967427/ · DOI: https://doi.org/10.1016/s0378-5173(00)00423-3
- Li B, et al. Effects of sucrose and mannitol on asparagine deamidation rates of model peptides in solution and in the solid state. J Pharm Sci. 2005;94(8):1723-35. PubMed: https://pubmed.ncbi.nlm.nih.gov/15986465/ · DOI: https://doi.org/10.1002/jps.20372
- Oliyai C, et al. Solid state chemical instability of an asparaginyl residue in a model hexapeptide. J Pharm Sci Technol. 1994;48(3):167-73. PubMed: https://pubmed.ncbi.nlm.nih.gov/8069519/
- Breen ED, et al. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res. 2001;18(9):1345-53. PubMed: https://pubmed.ncbi.nlm.nih.gov/11683251/ · DOI: https://doi.org/10.1023/a:1013054431517
- Hsu CC, et al. Determining the optimum residual moisture in lyophilized protein pharmaceuticals. Dev Biol Stand. 1992;74:255-70. PubMed: https://pubmed.ncbi.nlm.nih.gov/1592175/
- Zäh M, et al. Water Activity as an Indicator for Antibody Storage Stability in Lyophilized Formulations. Mol Pharm. 2025;22(2):918-926. PubMed: https://pubmed.ncbi.nlm.nih.gov/39809457/ · DOI: https://doi.org/10.1021/acs.molpharmaceut.4c01106
- Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75. PubMed: https://pubmed.ncbi.nlm.nih.gov/20143256/ · DOI: https://doi.org/10.1007/s11095-009-0045-6
For laboratory research use only.